Circulating extracellular vesicles as a potential source of new biomarkers of drug-induced liver injury

Toxicology Letters

Volumn 225, Issue 3, 2014, Pages 401-406

  Yang, Xi ^a   Weng, Zuquan ^a   Mendrick, Donna L ^a   Shi, Qiang ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Biomarkers; Drug induced liver injury; Exosomes; Extracellular vesicles

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER; MESSENGER RNA; MICRORNA 122; MICRORNA 155; MICRORNA;

CELL COMPARTMENTALIZATION; CELL ISOLATION; CELL VACUOLE; CIRCULATION; CULTURE MEDIUM; DISEASE SEVERITY; EXOSOME; EXTRACELLULAR VESICLE; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER INJURY; LYSOSOME; MICROARRAY ANALYSIS; MICROVESICLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TOXIC HEPATITIS; URINE; BLOOD; GENETICS; METABOLISM;

BIOLOGICAL MARKERS; DRUG-INDUCED LIVER INJURY; EXOSOMES; HEPATOCYTES; HUMANS; MICRORNAS; RNA, MESSENGER;

EID: 84893659345     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.01.013     Document Type: Review

References (56)

1. Alvarez M.L., Khosroheidari M., Kanchi Ravi R., DiStefano J.K. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney Int. 2012, 82:1024-1032.
2. Antoine D.J., Jenkins R.E., Dear J.W., Williams D.P., McGill M.R., Sharpe M.R., Craig D.G., Simpson K.J., Jaeschke H., Park B.K. Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. J. Hepatol. 2012, 56:1070-1079.
3. Antoine D.J., Dear J.W., Lewis P.S., Platt V., Coyle J., Masson M., Thanacoody R.H., Gray A.J., Webb D.J., Moggs J.G., Bateman D.N., Goldring C.E., Park B.K. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology 2013, 58:777-787.
4. Arroyo J.D., Chevillet J.R., Kroh E.M., Ruf I.K., Pritchard C.C., Gibson D.F., Mitchell P.S., Bennett C.F., Pogosova-Agadjanyan E.L., Stirewalt D.L., Tait J.F., Tewari M. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. P. Natl. Acad. Sci. USA 2011, 108:5003-5008.
5. Aubrecht J., Schomaker S.J., Amacher D.E. Emerging hepatotoxicity biomarkers and their potential to improve understanding and management of drug-induced liver injury. Genome Med. 2013, 5:85.
6. Bala S., Petrasek J., Mundkur S., Catalano D., Levin I., Ward J., Alao H., Kodys K., Szabo G. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 2012, 56:1946-1957.
7. Borlak J., Chatterji B., Londhe K.B., Watkins P.B. Serum acute phase reactants hallmark healthy individuals at risk for acetaminophen-induced liver injury. Genome Med. 2013, 5:86.
8. Channavajjhala S.K., Rossato M., Morandini F., Castagna A., Pizzolo F., Bazzoni F., Olivieri O. Optimizing the purification and analysis of miRNAs from urinary exosomes. Clinical chemistry and laboratory medicine: CCLM/FESCC. 2013, 52:1-10.
9. Conde-Vancells J., Rodriguez-Suarez E., Embade N., Gil D., Matthiesen R., Valle M., Elortza F., Lu S.C., Mato J.M., Falcon-Perez J.M. Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. J. Proteome Res. 2008, 7:5157-5166.
10. Conde-Vancells J., Rodriguez-Suarez E., Gonzalez E., Berisa A., Gil D., Embade N., Valle M., Luka Z., Elortza F., Wagner C., Lu S.C., Mato J.M., Falcon-Perez M. Candidate biomarkers in exosome-like vesicles purified from rat and mouse urine samples. Proteomics Clin. Appl. 2010, 4:416-425.
11. Corsini A., Ganey P., Ju C., Kaplowitz N., Pessayre D., Roth R., Watkins P.B., Albassam M., Liu B., Stancic S., Suter L., Bortolini M. Current challenges and controversies in drug-induced liver injury. Drug Saf. 2012, 35:1099-1117.
12. de Jong O.G., Verhaar M.C., Chen Y., Vader P., Gremmels H., Posthuma G., Schiffelers R.M., Gucek M., van Balkom B.W. Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. J Extracell Vesicles. 2012, 1.
13. de Vooght K.M., Lau C., de Laat P.P., van Wijk R., van Solinge W.W., Schiffelers R.M. Extracellular vesicles in the circulation: are erythrocyte microvesicles a confounder in the plasma haemoglobin assay?. Biochem. Soc. Trans. 2013, 41:288-292.
14. Eldh M., Lotvall J., Malmhall C., Ekstrom K. Importance of RNA isolation methods for analysis of exosomal RNA: evaluation of different methods. Mol. Immunol. 2012, 50:278-286.
15. FDA, 1997. Guidance for Industry: Drug Metabolism/Drug Interaction Studies in the Drug Development Process: Studies In Vitro.
16. FDA, 2009. Guidance for Industry: Drug-Induced Liver Injury: Premarketing Clinical Evaluation.
17. Gallo A., Tandon M., Alevizos I., Illei G.G. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PloS One 2012, 7:e30679.
18. Godoy P., Hewitt N.J., Albrecht U., Andersen M.E., Ansari N., Bhattacharya S., Bode J.G., Bolleyn J., Borner C., Bottger J., Braeuning A., Budinsky R.A., Burkhardt B., Cameron N.R., Camussi G., Cho C.S., Choi Y.J., Craig Rowlands J., Dahmen U., Damm G., Dirsch O., Donato M.T., Dong J., Dooley S., Drasdo D., Eakins R., Ferreira K.S., Fonsato V., Fraczek J., Gebhardt R., Gibson A., Glanemann M., Goldring C.E., Gomez-Lechon M.J., Groothuis G.M., Gustavsson L., Guyot C., Hallifax D., Hammad S., Hayward A., Haussinger D., Hellerbrand C., Hewitt P., Hoehme S., Holzhutter H.G., Houston J.B., Hrach J., Ito K., Jaeschke H., Keitel V., Kelm J.M., Kevin Park B., Kordes C., Kullak-Ublick G.A., LeCluyse E.L., Lu P., Luebke-Wheeler J., Lutz A., Maltman D.J., Matz-Soja M., McMullen P., Merfort I., Messner S., Meyer C., Mwinyi J., Naisbitt D.J., Nussler A.K., Olinga P., Pampaloni F., Pi J., Pluta L., Przyborski S.A., Ramachandran A., Rogiers V., Rowe C., Schelcher C., Schmich K., Schwarz M., Singh B., Stelzer E.H., Stieger B., Stober R., Sugiyama Y., Tetta C., Thasler W.E., Vanhaecke T., Vinken M., Weiss T.S., Widera A., Woods C.G., Xu J.J., Yarborough K.M., Hengstler J.G. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Archiv. Toxicol. 2013, 87:1315-1530.
19. Gonzales P.A., Pisitkun T., Hoffert J.D., Tchapyjnikov D., Star R.A., Kleta R., Wang N.S., Knepper M.A. Large-scale proteomics and phosphoproteomics of urinary exosomes. Journal of the American Society of Nephrology: JASN 2009, 20:363-379.
20. Huang X., Yuan T., Tschannen M., Sun Z., Jacob H., Du M., Liang M., Dittmar R.L., Liu Y., Liang M., Kohli M., Thibodeau S.N., Boardman L., Wang L. Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics 2013, 14:319.
21. Hussaini S.H., Farrington E.A. Idiosyncratic drug-induced liver injury: an update on the 2007 overview. Expert Opin Drug Saf. 2014, 13:67-81.
22. Kalra H., Adda C.G., Liem M., Ang C.S., Mechler A., Simpson R.J., Hulett M.D., Mathivanan S. Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma. Proteomics. 2013, 13:3354-3364.
23. Kucharzewska P., Christianson H.C., Welch J.E., Svensson K.J., Fredlund E., Ringner M., Morgelin M., Bourseau-Guilmain E., Bengzon J., Belting M. Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. P. Natl. Acad. Sci. USA 2013, 110:7312-7317.
24. Lasser C., Alikhani V.S., Ekstrom K., Eldh M., Paredes P.T., Bossios A., Sjostrand M., Gabrielsson S., Lotvall J., Valadi H. Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J. Translational Med. 2011, 9:9.
25. Lasser C., lsquo O., Neil S.E., Ekerljung L., Ekstrom K., Sjostrand M., Lotvall J. RNA-containing exosomes in human nasal secretions. American journal of rhinology & allergy 2011, 25:89-93.
26. Levanen B., Bhakta N.R., Torregrosa Paredes P., Barbeau R., Hiltbrunner S., Pollack J.L., Skold C.M., Svartengren M., Grunewald J., Gabrielsson S., Eklund A., Larsson B.M., Woodruff P.G., Erle D.J., Wheelock A.M. Altered microRNA profiles in bronchoalveolar lavage fluid exosomes in asthmatic patients. J. Allergy Clin. Immunol. 2013, 131:894-903.
27. Llorente A., Skotland T., Sylvanne T., Kauhanen D., Rog T., Orlowski A., Vattulainen I., Ekroos K., Sandvig K. Molecular lipidomics of exosomes released by PC-3 prostate cancer cells. Biochim. Biophys. Acta 2013, 1831:1302-1309.
28. Masyuk A.I., Masyuk T.V., Larusso N.F. Exosomes in the pathogenesis, diagnostics and therapeutics of liver diseases. J. Hepatol. 2013, 59:621-625.
29. McGill M.R., Jaeschke H. Apoptosis or necrosis in acetaminophen-induced acute liver failure?. New insights from mechanistic biomarkers*. Crit. Care Med. 2013, 41:2653-2654.
30. Mendrick D.L. Transcriptional profiling to identify biomarkers of disease and drug response. Pharmacogenomics 2011, 12:235-249.
31. Miyamoto M., Yanai M., Ookubo S., Awasaki N., Takami K., Imai R. Detection of cell-free, liver-specific mRNAs in peripheral blood from rats with hepatotoxicity: a potential toxicological biomarker for safety evaluation. Toxicol. Sci.: An Official Journal of the Society of Toxicology 2008, 106:538-545.
32. Momen-Heravi F., Balaj L., Alian S., Mantel P.Y., Halleck A.E., Trachtenberg A.J., Soria C.E., Oquin S., Bonebreak C.M., Saracoglu E., Skog J., Kuo W.P. Current methods for the isolation of extracellular vesicles. Biol. Chem. 2013, 394:1253-1262.
33. Murakami Y., Toyoda H., Tanahashi T., Tanaka J., Kumada T., Yoshioka Y., Kosaka N., Ochiya T., Taguchi Y.H. Comprehensive miRNA expression analysis in peripheral blood can diagnose liver disease. PloS One 2012, 7:e48366.
34. Okubo S., Miyamoto M., Takami K., Kanki M., Ono A., Nakatsu N., Yamada H., Ohno Y., Urushidani T. Identification of novel liver-specific mRNAs in plasma for biomarkers of drug-induced liver injury and quantitative evaluation in rats treated with various hepatotoxic compounds. Toxicol. Sci.: An Official Journal of the Society of Toxicology 2013, 132:21-31.
35. Poliakov A., Spilman M., Dokland T., Amling C.L., Mobley J.A. Structural heterogeneity and protein composition of exosome-like vesicles (prostasomes) in human semen. The Prostate 2009, 69:159-167.
36. Raposo G., Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 2013, 200:373-383.
37. Regev A. How to avoid being surprised by hepatotoxicity at the final stages of drug development and approval. Clin. Liver Dis. 2013, 17:749-767.
38. Ribeiro R.M., Layden-Almer J., Powers K.A., Layden T.J., Perelson A.S. Dynamics of alanine aminotransferase during hepatitis C virus treatment. Hepatology 2003, 38:509-517.
39. Royo F., Falcon-Perez J.M. Liver extracellular vesicles in health and disease. J Extracell Vesicles. 2012, 1.
40. Royo F., Schlangen K., Palomo L., Gonzalez E., Conde-Vancells J., Berisa A., Aransay A.M., Falcon-Perez J.M. Transcriptome of extracellular vesicles released by hepatocytes. PloS One 2013, 8:e68693.
41. Shi Q., Hong H., Senior J., Tong W. Biomarkers for drug-induced liver injury. Expert Rev. Gastroenter. Hepatol. 2010, 4:225-234.
42. Shi Q., Yang X., Greenhaw J., Salminen W.F. Hepatic cytochrome P450s attenuate the cytotoxicity induced by leflunomide and its active metabolite A77 1726 in primary cultured rat hepatocytes. Toxicol. Sci.: An Official Journal of the Society of Toxicology 2011, 122:579-586.
43. Shi Q., Yang X., Mendrick D.L. Hopes and challenges in using miRNAs as translational biomarkers for drug-induced liver injury. Biomarkers Med. 2013, 7:307-315.
44. Starkey Lewis P.J., Dear J., Platt V., Simpson K.J., Craig D.G., Antoine D.J., French N.S., Dhaun N., Webb D.J., Costello E.M., Neoptolemos J.P., Moggs J., Goldring C.E., Park B.K. Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 2011, 54:1767-1776.
45. Street J.M., Barran P.E., Mackay C.L., Weidt S., Balmforth C., Walsh T.S., Chalmers R.T., Webb D.J., Dear J.W. Identification and proteomic profiling of exosomes in human cerebrospinal fluid. J. Translational Med. 2012, 10:5.
46. Tolosa L., Pinto S., Donato M.T., Lahoz A., Castell J.V., O'Connor J.E., Gomez-Lechon M.J. Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs. Toxicol. Sci.: An Official Journal of the Society of Toxicology 2012, 127:187-198.
47. Turchinovich A., Weiz L., Langheinz A., Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011, 39:7223-7233.
48. van der Pol E., Boing A.N., Harrison P., Sturk A., Nieuwland R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol. Rev. 2012, 64:676-705.
49. Wang K., Zhang S., Marzolf B., Troisch P., Brightman A., Hu Z., Hood L.E., Galas D.J. Circulating microRNAs, potential biomarkers for drug-induced liver injury. P. Natl. Acad. Sci. USA 2009, 106:4402-4407.
50. Welker M.W., Reichert D., Susser S., Sarrazin C., Martinez Y., Herrmann E., Zeuzem S., Piiper A., Kronenberger B. Soluble serum CD81 is elevated in patients with chronic hepatitis C and correlates with alanine aminotransferase serum activity. PloS One 2012, 7:e30796.
51. Wetmore B.A., Brees D.J., Singh R., Watkins P.B., Andersen M.E., Loy J., Thomas R.S. Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury. Hepatology 2010, 51:2127-2139.
52. Witwer K.W., Buzas E.I., Bemis L.T., Bora A., Lasser C., Lotvall J., Nolte-, rsquo, Hoen E.N., Piper M.G., Sivaraman S., Skog J., Thery C., Wauben M.H., Hochberg F. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research,. J Extracell Vesicles 2013, 2.
53. Xu J.J., Henstock P.V., Dunn M.C., Smith A.R., Chabot J.R., de Graaf D. Cellular imaging predictions of clinical drug-induced liver injury. Toxicol. Sci.: An Official Journal of the Society of Toxicology 2008, 105:97-105.
54. Yamaura Y., Nakajima M., Takagi S., Fukami T., Tsuneyama K., Yokoi T. Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis. PloS One 2012, 7:e30250.
55. Yang X., Greenhaw J., Shi Q., Su Z., Qian F., Davis K., Mendrick D.L., Salminen W.F. Identification of urinary microRNA profiles in rats that may diagnose hepatotoxicity. Toxicol. Sci.: An Official Journal of the Society of Toxicology 2012, 125:335-344.
56. Yun J.W., Lee T.R., Kim C.W., Park Y.H., Chung J.H., Lee Y.S., Kang K.S., Lim K.M. Predose blood gene expression profiles might identify the individuals susceptible to carbon tetrachloride-induced hepatotoxicity. Toxicol. Sci.: An Official Journal of the Society of Toxicology 2010, 115:12-21.